Literature DB >> 10229336

Localisation of dehydroepiandrosterone sulphotransferase in adult rat brain.

S Aldred1, R H Waring.   

Abstract

The presence and localisation of dehydroepiandrosterone sulphotransferase was assessed in adult rat brain. The activity of the enzyme was investigated and was found to be approximately four times less than that in rat liver. Rat brain dehydroepiandrosterone sulphotransferase activity was measured as 1.39+/-0.04 nm/microg/min. The protein expression of dehydroepiandrosterone sulphotransferase was evaluated using Western blotting. The presence of a band at 35 kDa signified the presence of this enzyme in adult rat brain. Finally, the localisation of this enzyme was investigated by immunohistochemistry and by assessing activity in nine regions of brain. Immunohistochemistry showed positive staining in the hippocampus and the dendate gyrus, and in the large neurons of the midbrain, indicating the presence of dehydroepiandrosterone sulphotransferase. Western blotting showed the presence of a band in all nine regions, and enzyme activity was highest in the hippocampus, frontal cortex, thalamus and basal ganglia. These results imply that dehydroepiandrosterone and dehydroepiandrosterone sulphate (DHEAS) have a defined role in brain function and are produced in situ independently of the peripheral endocrine system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229336     DOI: 10.1016/s0361-9230(98)00172-5

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  2 in total

1.  Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain.

Authors:  C N Falany; X Xie; J Wang; J Ferrer; J L Falany
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

Review 2.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

Authors:  Nicole Maninger; Owen M Wolkowitz; Victor I Reus; Elissa S Epel; Synthia H Mellon
Journal:  Front Neuroendocrinol       Date:  2008-12-03       Impact factor: 8.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.